MYL4715OO008
MYL4715OO008
GENM
Loading chart...
Elevated Business & Solvency Risk
Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 35/100).
Volatility Risk
Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.
Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta
Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.5x).
Beta (Market Relation)
0.52x
DefensiveVolatility (5Y p.a.)
24.3% p.a.
5-Year HorizonMax Drawdown (5Y)
-55.8%
5-Year HorizonSharpe Ratio
-0.68
Return / RiskSpeculative / High Risk: Score Basis:
Multi-Horizon Risk & Performance Matrix
Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.
Volatility Expansion (3Y > 5Y)
Timeframe | Volatility (p.a.) | Max Drawdown | Sharpe Ratio | Return (p.a.) |
|---|---|---|---|---|
| 1 Year | — | — | — | -31.3% |
| 3 Years | 26.7% | -50.3% | -0.67 | -15.5% |
| 5 Years | 24.3% | -55.8% | -0.68 | -13.8% |
| 10 Years | 29.0% | -76.6% | -0.46 | -10.8% |
Automated Risk & Health Notes (Red Flags)
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Strong cyclicality: The business model is sensitive to economic downturns.
Historical Stress Test: Maximum peak-to-trough drawdown of -76.6% in the extended horizon.